
Biobrix helps pharma and biotech companies speed up drug discovery using AI-powered cell morphology analysis. It combines artificial intelligence with detailed cell morphology data to identify promising compounds more efficiently. Core tech includes image-based morphology analysis and machine learning models for high-throughput screening. Based in Paris, it serves global pharma and biotech researchers seeking faster discovery timelines. The approach aims to reduce development time and overall costs in early-stage drug research.

Biobrix helps pharma and biotech companies speed up drug discovery using AI-powered cell morphology analysis. It combines artificial intelligence with detailed cell morphology data to identify promising compounds more efficiently. Core tech includes image-based morphology analysis and machine learning models for high-throughput screening. Based in Paris, it serves global pharma and biotech researchers seeking faster discovery timelines. The approach aims to reduce development time and overall costs in early-stage drug research.